CClinicalTrials.gg
CompletedNCT05259124Updated Aug 25, 2023

The Ability of Perfusion Index and Positional Perfusion Index Variation to Predict Spinal Anesthesia-induced Hypotension in Elderly Patients

An observational study in Spinal Anesthesia Induced Hypotension, sponsored by Cairo University. Completed at 1 site in Egypt. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2023-08-25.

Sponsored by Cairo University · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
68
Ages
65 Years and older
Sex
All
01

Study summary

In this study, we will test the ability of positional perfusion index variation to predict post-spinal anesthesia hypotension in elderly patients.

02

Conditions studied

  • Spinal Anesthesia Induced Hypotension

Browse trials for

03

In context

Hypotension

1,003 studies on the registry are indexed under Hypotension; 173 are open to participants now.

This study's enrollment of 68 is below the median of 84 across 294 observational studies indexed under Hypotension.

Browse Hypotension studies →

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

A total of 68 consecutive elderly patients, aged >65 years scheduled for elective surgical operations under spinal anesthesia will be included in the study.

Inclusion criteria

  • 65 years of age or more.
  • ASA score I \& II.
  • Patients scheduled for surgeries under spinal anesthesia.

Exclusion criteria

Exclusion Criteria:

  • Negative consent.
  • pre-existing hypertension
  • Diabetes mellitus or autonomic neuropathy.
  • Emergency operations.
  • Absolute contraindications or failure to perform spinal anesthesia.
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
68 participants (actual)
Patient registry
No

Interventions

  • Devicepositional perfusion index variation

    positional perfusion index variation to predict spinal anesthesia-induced hypotension in elderly patients

06

What researchers measure

Primary outcomes

  1. The sensitivity of perfusion index postural change in predicting spinal anesthesia-induced hypotension in elderly patients.

    The sensitivity of incremental change of a measured perfusion index pre and post spinal anesthesia

    Time frame: 30 minutes after spinal anesthesia

Secondary outcomes

  1. incidence of spinal anesthesia induced hypotension in elderly

    incidence of spinal anesthesia induced hypotension in elderly

    Time frame: 30 minutes after spinal anesthesia

  2. • The sensitivity of supine perfusion index to predict spinal anesthesia-induced hypotension in elderly patients.

    • The sensitivity of supine perfusion index to predict spinal anesthesia-induced hypotension in elderly patients.

    Time frame: 30 minutes after spinal anesthesia

  3. • The sensitivity of sitting perfusion index to predict spinal anesthesia-induced hypotension in elderly patients.

    • The sensitivity of sitting perfusion index to predict spinal anesthesia-induced hypotension in elderly patients.

    Time frame: 30 minutes after spinal anesthesia

07

Study locations

1 site
  • Cairo university hospital
    Cairo, Giza 202, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 25, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05259124
Lead sponsor
Cairo University
Responsible party
Amr Ahmed Mahmoud AbdelKader (principal investigator, Cairo University) — Principal investigator
First posted
Feb 28, 2022
Start date
Jun 3, 2022
Primary completion
Aug 23, 2023
Completion
Aug 23, 2023
Last update
Aug 25, 2023

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion